Home > PJ (current issue) > CPD

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7469 p299-302
15 September 2007

This article
Reprint   Photocopy

PDF 80K, Acrobat Reader

Continuing professional development

Breast cancer: an overview

In the first of two articles, Sandra Melville and Lucy Heycock outline the pathology of breast cancer and the role pharmacists can play in prevention and patient support

Continuing professional development articles

Breast cancer series


Sandra Melville, BSc, MRPharmS, is clinical pharmacist at Lorn & Islands District General Hospital, Oban, Argyll, and Lucy Heycock, MSc (cancer nursing), is a Macmillan nurse specialist

Anatomical Travelogue / Science Photo Library

SUMMARY

Breast cancer affects almost 42,000 people in the UK each year and there are 12,700 deaths from the disease annually — it is the most common cause of death in women between the ages of 35 and 55 years.

One in nine women in the UK will develop breast cancer and although the incidence is increasing, recent advances in prevention and screening together with new treatments have resulted in improved survival rates.

Breast cancer also occurs in men, accounting for 1 per cent of cases in the UK.

However, this series only applies to breast cancer in women.

Pharmacists, particularly in the community, are ideally placed not only to give lifestyle advice about risk reduction, but also to act as a valuable resource for patients experiencing side effects during treatment.

Full article PDF 80K

Risk factors for developing breast cancer

Age Incidence increases from one in 900 in those under 30 years old to one in 10 in those over 85 years.

Oestrogen therapy Oral contraceptives slightly increase the risk of breast cancer. Hormone replacement therapy increases the risk of breast cancer and decreases sensitivity of mammography.

Obesity Women who are obese, particularly post menopause, are at increased risk. Adipose tissue is the main body source of oestrogen after menopause.

Menstrual and pregnancy history Early menarche, late menopause, fewer pregnancies and shorter duration of breastfeeding are all associated with increased risk.

Race Variations are seen with age and race. In women under 40 years old, Caucasian women are more likely than black or Asian women to develop breast cancer, while in women over 40 years black women are at increased risk compared with Caucasian or Asian women. Asian women of all ages are at a decreased risk.

Family history A small proportion of breast cancers have a strong genetic link. Carrying the BRCA1 or BRCA2 gene mutation leads to a 50–80 per cent chance of developing breast cancer.

Height at age 14 Women who were taller than 165cm at the age of 14 years are at increased risk and those under 150cm at the age of 14 years are at decreased risk. (Women in between these heights are at average risk.)

Birth weight Women who weighed over 4.43kg at birth are at increased risk and those weighing less than 3.18kg are at decreased risk.

Socio-economic status There is a positive correlation between risk and socio-economic status — those of higher status are at greater risk.

Geographical location Women in urban areas are at higher risk than those in rural areas.

Back to Top


©The Pharmaceutical Journal